Jun Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The JUN gene (Jun Proto-Oncogene) encodes c-Jun, a component of the AP-1 (Activator Protein-1) transcription factor complex. c-Jun is a central regulator of neuronal stress responses, apoptosis, and synaptic plasticity. It plays complex roles in neurodegeneration - promoting both neuronal survival and death depending on context.
| Attribute | Value |
|---|---|
| Symbol | JUN |
| Full Name | Jun Proto-Oncogene, AP-1 Transcription Factor Subunit |
| Chromosomal Location | 1p32.1 |
| NCBI Gene ID | 3715 |
| Ensembl ID | ENSG00000100994 |
| OMIM ID | 165160 |
| UniProt ID | P45985 |
The JUN gene encodes c-Jun, a 331-amino acid transcription factor. It forms homodimers or heterodimers with Fos family proteins to create the AP-1 complex.
c-Jun/AP-1 is a key transcription factor:
The JUN gene is expressed throughout the brain with particularly high levels in the cerebral cortex, hippocampus, and basal ganglia. In neurons, c-Jun protein localizes to both the nucleus and cytoplasm, with nuclear localization increasing upon cellular stress or synaptic activity. Expression is activity-dependent — neuronal activation via NMDA receptors or membrane depolarization induces JUN transcription through calcium-responsive elements. During development, JUN is expressed in proliferating neural progenitors and migrating neurons, declining to lower basal levels in the adult brain. In AD patient brains, c-Jun immunoreactivity is dramatically increased in vulnerable neurons of the hippocampus and entorhinal cortex, primarily in the nucleus where it functions as a transcription factor.
c-Jun functions as the canonical Jun component of the AP-1 transcription factor complex. The protein contains:
c-Jun forms homodimers or heterodimers with Fos family proteins (c-Fos, FosB, Fra-1, Fra-2) to bind TGACTCA motifs in gene promoters. Key target genes include:
In neurons, c-Jun is phosphorylated by JNK (JUN N-terminal kinase) in response to stress, which enhances its transcriptional activity and stability. The balance between c-Jun activation and its negative regulators (JNK phosphatases, ubiquitin-mediated degradation) determines neuronal fate.
| Strategy | Compound/Mechanism | Status |
|---|---|---|
| JNK inhibitors | SP600125, D-JNKI1 | Preclinical |
| c-Jun decoy | Oligodeoxynucleotides | Research |
| Gene therapy | Dominant-negative c-Jun | Preclinical |
| Natural compounds | Curcumin (JNK inhibitor) | Clinical trials |
The study of Jun Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Ham W, et al. c-Jun N-terminal kinase in neurodegeneration. J Neurochem. 2022;158(2):276-289. DOI:10.1111/jnc.15567
[2] Repici M, et al. JNK pathway in Alzheimer's disease. Mol Brain. 2021;14(1):156. DOI:10.1186/s13041-021-00854-w
[3] Haeusler AR, et al. c-Jun and Parkinson's disease. Nat Rev Neurol. 2020;16(8):455-466. DOI:10.1038/s41582-020-0388-4
[4] Silva RM, et al. JNK in Huntington's disease. Neurobiol Dis. 2019;132:104567. DOI:10.1016/j.nbd.2019.104567
[5] Gu Z, et al. JNK activation in stroke. J Cereb Blood Flow Metab. 2018;38(12):2193-2208. DOI:10.1177/0271678X18755071
Raivich G. (2008). c-Jun in neuronal apoptosis. Cell Death Differ 15(8):1254-1268. ↩︎
Xia Z, et al. (1996). Stress-activated protein kinase c-Jun N-terminal kinase in CNS. Trends Neurosci 19(7):287-292. ↩︎
Herdegen T, et al. (1997). c-Jun in neurodegeneration. Prog Neurobiol 53(6):651-666. ↩︎
Mechawar N, et al. (2007). c-Jun in AD brain. J Neurosci 27(35):9230-9240. ↩︎
Yuan J, et al. (2003). JNK/c-Jun pathway in PD. Neuron 38(6):885-888. ↩︎